Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session 2: GU tumours, non-prostate

Invited Discussant 1736MO and 1737MO


12 Sep 2022


Mini Oral session 2: GU tumours, non-prostate


Translational Research;  Immunotherapy

Tumour Site

Urothelial Cancer


Michiel van der Heijden


M.S. van der Heijden

Author affiliations

  • Medical Oncology Department, Netherlands Cancer Institute, 1006 BE - Amsterdam/NL


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.